1. Home
  2. CDNA vs UWMC Comparison

CDNA vs UWMC Comparison

Compare CDNA & UWMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • UWMC
  • Stock Information
  • Founded
  • CDNA 1998
  • UWMC 1986
  • Country
  • CDNA United States
  • UWMC United States
  • Employees
  • CDNA N/A
  • UWMC N/A
  • Industry
  • CDNA Medical Specialities
  • UWMC Finance: Consumer Services
  • Sector
  • CDNA Health Care
  • UWMC Finance
  • Exchange
  • CDNA Nasdaq
  • UWMC Nasdaq
  • Market Cap
  • CDNA 944.1M
  • UWMC 949.1M
  • IPO Year
  • CDNA 2014
  • UWMC N/A
  • Fundamental
  • Price
  • CDNA $22.79
  • UWMC $6.17
  • Analyst Decision
  • CDNA Buy
  • UWMC Hold
  • Analyst Count
  • CDNA 8
  • UWMC 7
  • Target Price
  • CDNA $27.17
  • UWMC $7.68
  • AVG Volume (30 Days)
  • CDNA 816.5K
  • UWMC 3.5M
  • Earning Date
  • CDNA 11-04-2024
  • UWMC 11-07-2024
  • Dividend Yield
  • CDNA N/A
  • UWMC 6.63%
  • EPS Growth
  • CDNA N/A
  • UWMC N/A
  • EPS
  • CDNA N/A
  • UWMC N/A
  • Revenue
  • CDNA $312,775,000.00
  • UWMC $2,727,467,000.00
  • Revenue This Year
  • CDNA $19.60
  • UWMC $5.43
  • Revenue Next Year
  • CDNA $10.26
  • UWMC $24.97
  • P/E Ratio
  • CDNA N/A
  • UWMC N/A
  • Revenue Growth
  • CDNA 5.26
  • UWMC 29.95
  • 52 Week Low
  • CDNA $7.42
  • UWMC $5.42
  • 52 Week High
  • CDNA $34.84
  • UWMC $9.74
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 42.58
  • UWMC 39.65
  • Support Level
  • CDNA $21.16
  • UWMC $5.83
  • Resistance Level
  • CDNA $24.42
  • UWMC $6.21
  • Average True Range (ATR)
  • CDNA 1.30
  • UWMC 0.28
  • MACD
  • CDNA 0.16
  • UWMC 0.06
  • Stochastic Oscillator
  • CDNA 43.83
  • UWMC 41.75

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About UWMC UWM Holdings Corporation

UWM Holdings Corp engages in the origination, sale and servicing of residential mortgage loans. The company provides independent mortgage advisors across the states and the district of Columbia.

Share on Social Networks: